Evidence map›Paper›PMID 25164815›Full record

ArticleThe Journal of biological chemistry2014

Distinct biochemical and functional properties of two Rab5 homologs from the rice blast fungus Magnaporthe oryzae.

Yaoyao Qi, M Caleb Marlin, Zhimin Liang, William L Berry, Ralf Janknecht, Jie Zhou, Zonghua Wang, Guodong Lu, Guangpu Li

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. International journal of molecular sciences · 2019
    Article
  5. Article
  6. Article
  7. Article
  8. Determination of Rab5 activity in the cell by effector pull-down assay.Methods in molecular biology (Clifton, N.J.) · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Yaoyao QiFrom the Key Laboratory of Biopesticides and Chemical Biology, Ministry of Education, Fujian Agriculture and Forestry University, Fuzhou, Fujian, 350002, China, and Departments of Biochemistry and Molecular Biology.
M Caleb MarlinDepartments of Biochemistry and Molecular Biology.
Zhimin LiangDepartments of Biochemistry and Molecular Biology.
William L BerryCell Biology, and.
Ralf JanknechtCell Biology, and Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104.
Jie ZhouFrom the Key Laboratory of Biopesticides and Chemical Biology, Ministry of Education, Fujian Agriculture and Forestry University, Fuzhou, Fujian, 350002, China, and.
Zonghua WangFrom the Key Laboratory of Biopesticides and Chemical Biology, Ministry of Education, Fujian Agriculture and Forestry University, Fuzhou, Fujian, 350002, China, and.
Guodong LuFrom the Key Laboratory of Biopesticides and Chemical Biology, Ministry of Education, Fujian Agriculture and Forestry University, Fuzhou, Fujian, 350002, China, and gdlufafu@163.com.
Guangpu LiDepartments of Biochemistry and Molecular Biology, Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104 guangpu-li@ouhsc.edu.
University of Oklahoma Health Sciences Center · USFujian Agriculture and Forestry University · CN

Funding

Structural and Functional Specificity of Rab GTPasesR01GM074692 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LI, GUANGPU · 2006 to 2015
$2.4M
NIGMS NIH HHS R01 GM074692NIGMS NIH HHS R01GM074692
6 · The paper itself

Abstract

Rab5 is a key regulator of early endocytosis by promoting early endosomal fusion and motility. In this study, we have unexpectedly found distinct properties of the two Rab5 homologs (MoRab5A and MoRab5B) from Magnaporthe oryzae, a pathogenic fungus in plants whose infection causes rice blast disease. Like mammalian Rab5, MoRab5A and MoRab5B can bind to several Rab5 effectors in a GTP-dependent manner, including EEA1, Rabenosyn-5, and Rabaptin-5. However, MoRab5A shows distinct binding characteristics in the sense that both the wild-type and the GTP hydrolysis-defective constitutively active mutant bind the effectors equally well in GST pull-down assays, suggesting that MoRab5A is defective in GTP hydrolysis and mostly in the GTP-bound conformation in the cell. Indeed, GTP hydrolysis assays indicate that MoRab5A GTPase activity is dramatically lower than MoRab5B and human Rab5 and is insensitive to RabGAP5 stimulation. We have further identified a Pro residue in the switch I region largely responsible for the distinct MoRab5A properties by characterization of MoRab5A and MoRab5B chimeras and mutagenesis. The differences between MoRab5A and MoRab5B extend to their functions in the cell. Although they both target to early endosomes, only MoRab5B closely resembles human Rab5 in promoting early endosome fusion and stimulating fluid phase endocytosis. In contrast, MoRab5A correlates with another related early endosomal Rab, Rab22, in terms of the presence of the switch I Pro residue and the blocked GTPase activity. Our data thus identify MoRab5B as the Rab5 ortholog and suggest that MoRab5A specializes to perform a non-redundant function in endosomal sorting.

Indexed as

Gene Expression Regulation, FungalAmino Acid SequenceEndocytosisEndosomesEscherichia coliFungal ProteinsGuanosine TriphosphateHumansHydrolysisMagnaportheMolecular Sequence DataMutant Chimeric ProteinsOryzaPlant DiseasesProtein BindingProtein IsoformsFungal ProteinsGuanosine TriphosphateMutant Chimeric ProteinsProtein Isoformsrab5 GTP-Binding ProteinsVesicular Transport ProteinsEndocytosisEndosomeFungiGTPaseGTP HydrolysisMagnaportheRab

Identifiers

PMID25164815
PMCPMC4192484
OpenAlexW2012653610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.